Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Custodiol-N versus Custodiol in Pediatric Congenital Heart Surgery
2024-511517-38-00Phase 2Suspended
- Sponsor
- Franz Köhler Chemie
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of histidine-tryptophan-ketoglutarate solution (modified) in Cardiovascular Malformation (CVM) (2 arms), sponsored by Franz Köhler Chemie. Primary endpoints: Safety assessment via adverse events and Myocardial protection assessed by CK-MB. Started Aug 2024; status: suspended.
02
Drugs
histidine-tryptophan-ketoglutarate solution (modified)
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on 2024-511517-38-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511517-38-00.